Evidence map›Paper›PMID 36505370›Full record

ArticleFrontiers in cardiovascular medicine2022

Clinical significance of the series of

Dongxu Wang, Hualan Wu, Min Dong, Qing Zhang, Anxu Zhao, Xinlong Zhao, Jia Chong, Minghui Du, Yan Wang, Haifeng Shi and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Identification andFrontiers in endocrinology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Dongxu WangDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Hualan WuDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Min DongDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Qing ZhangDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Anxu ZhaoDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Xinlong ZhaoDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Jia ChongDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Minghui DuDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Yan WangDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Haifeng ShiDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Shuanghu WangLaboratory of Clinical Pharmacy, The People's Hospital of Lishui, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
Fang WangDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Jianping CaiThe Key Laboratory of Geriatrics, National Centre of Gerontology, Beijing Hospital, Beijing Institute of Geriatrics, Beijing, China.
Jiefu YangDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Dapeng DaiThe Key Laboratory of Geriatrics, National Centre of Gerontology, Beijing Hospital, Beijing Institute of Geriatrics, Beijing, China.
Hao ChenDepartment of Cardiology, National Center of Gerontology, Beijing Hospital, Beijing, China.
Beijing Hospital · CNBeijing Geriatric Hospital · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backgrounds: Gene polymorphisms are critical for variations in warfarin dose. To date, more than 70 Methods: The entire Results: A total of 20 Conclusion: Our results showed that, besides

Indexed as

alleleanticoagulationCYP2C9gene polymorphismwarfarin

Identifiers

PMID36505370
PMCPMC9729276
OpenAlexW4309842688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.